About the necessity to manage events coded with MedDRA prior to statistical analysis: Proposal of a strategy with application to a randomized clinical trial, ANRS 099 ALIZE

Contemporary Clinical Trials

Volumn 29, Issue 2, 2008, Pages 95-101

  Journot, Valérie ^a   Tabuteau, Sophie ^a   Collin, Fidéline ^a   Molina, Jean Michel ^b,c   Chene, Geneviève ^a,d,e   Rancinan, Corinne ^a  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Event retrieval; MedDRA; Safety report

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ;

ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EAR DISEASE; GASTROINTESTINAL DISEASE; HEPATOBILIARY DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNER EAR DISEASE; MEDICAL DICTIONARY FOR REGULATORY ACTIVITIES; MEDICAL RESEARCH; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NEUROTOXICITY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 39149122160     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2007.05.007     Document Type: Article

References (24)

1. European Parliament, European Council. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities L 121 (2001) 34-44
2. European Commission. Detailed guidance on the collection, verification and presentation of adverse reaction reports arising from clinical trials on medicinal products for human use. Revision 2 (2006). http://eudravigilance.emea.europa.eu/human/euPoliciesAndDocs.asp [http://eudravigilance.emea.europa.eu/human/euPoliciesAndDocs.asp]. Accessed September 19, 2006
3. Brown E.G., Wood L., and Wood S. The Medical Dictionary for Regulatory Activities (MedDRA). Drug Saf 20 2 (1999) 109-117
4. ICH Points to consider Working Group. MedDRA® term selection: points to consider. ICH-endorsed guide for MedDRA users: application to adverse drug reactions/adverse events & medical and social history & indications. Release 3.6, based on MedDRA Version 9.0. ICH: MedDRA Documents. 2006. [http://www.ich.org/]. Accessed September 19, 2006.
5. ICH Points to consider Working Group. MedDRA® data retrieval and presentation: points to consider. ICH-endorsed guide for MedDRA users on data output. Release 1.1, based on MedDRA Version 9.0. ICH: MedDRA Documents. 2006. [http://www.ich.org/]. Accessed September 19, 2006.
6. Marschner M. Standardization in the data management of clinical trials based on MedDRA. Pharm Ind 66 5a (2004) 619-622
7. Tonéatti C., Saïdi Y., Meiffrédy V., et al. Experience using MedDRA for global events coding in HIV clinical trials. Contemp Clin Trials 27 (2006) 13-22
8. Brown E.G. Effects of coding dictionary on signal generation: a consideration of use of MedDRA compared with WHO-ART. Drug Saf 25 6 (2002) 445-452
9. Brown E.G. Using MedDRA: implications for risk management. Drug Saf 27 8 (2004) 591-602
10. Bousquet C., Hénégar C., Lillo-Le Louët A., Degoulet P., and Jaulenta M.C. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach. Int J Med Inform 74 (2005) 563-571
11. Hénégar C., Bousquet C., Lillo-Le Louët A., Degoulet P., and Jaulent M.C. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance. Comput Biol Med 36 7-8 (2006) 748-767
12. Thiessard F., Roux E., Miremont-Salamé G., et al. Trends in spontaneous adverse drug reaction reports to the French Pharmacovigilance System (1986-2001). Drug Saf 28 8 (2005) 731-740
13. Schroeder J.R., Schmittner J.P., Epstein D.H., and Preston K.L. Adverse events among patients in a behavioral treatment trial for heroin and cocaine dependence: effects of age, race, and gender. Drug Alcohol Depend 80 1 (2005) 45-51
14. Strang N., Cucherat M., and Boissel J.P. Which coding system for therapeutic information in evidence-based medicine. Comput Methods Programs Biomed 68 (2002) 73-85
15. Klepper M.J. The periodic safety update report as a pharmacovigilance tool. Drug Saf 27 8 (2004) 569-578
16. Molina J.M., Journot V., Morand-Joubert L., et al. Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial. J Infect Dis 191 (2005) 830-839
17. Carr A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 7 (1998) F51-F58
18. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 21 (2003) 1993-2003
19. Journot V., Chêne G., De Castro N., et al. Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099. Clin Infect Dis 42 12 (2006) 1790-1799
20. Brown E.G. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA). [erratum appears in Drug Saf 2004;27(1):61]. Drug Saf 26 3 (2003) 145-158
21. Bousquet C., Lagier G., Lillo-Le Louët A., et al. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions. Drug Saf 28 1 (2005) 19-34
22. Kübler J., Vonk R., Beimel S., et al. Adverse event analysis and MedDRA: Business as usual or challenge?. Drug Inf J 39 (2005) 63-72
23. Zhao-Wong A.C., Rump E., Moraleda T., Mozzicato P., and Revelle P. Proposed terminology changes to facilitate the analysis of MedDRA®-coded data. Drug Inf J 40 (2006) 291-303
24. CIOMS Working Group for SMQs. List of SMQ topics for development by CIOMS Working Group for SMQs (as of 28 Feb 2007). MSSO: Standardized MedDRA Queries (SMQs). 2007. [http://www.meddramsso.com/MSSOWeb/SMQ/smqlist.htm]. Accessed 24 May, 2007.